HILARY LOTT: Open Payments
NPI 1184107898 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 68 payments from 17 companies in 2025. Trend: 2023 $1,018 · 2024 $1,242 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $230 |
| Novo Nordisk Inc | 7 | $212 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Lilly USA, LLC | 9 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| PFIZER INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Lundbeck LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
Products named: REXULTI, Ozempic, MOUNJARO, QULIPTA, VRAYLAR, TRINTELLIX, NURTEC ODT, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
